Key Insights

Highlights

Success Rate

82% trial completion

Published Results

17 trials with published results (13%)

Research Maturity

73 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.1%

16 terminated out of 132 trials

Success Rate

82.0%

-4.5% vs benchmark

Late-Stage Pipeline

8%

10 trials in Phase 3/4

Results Transparency

23%

17 of 73 completed with results

Key Signals

17 with results82% success16 terminated

Data Visualizations

Phase Distribution

71Total
Not Applicable (23)
Early P 1 (1)
P 1 (8)
P 2 (29)
P 3 (9)
P 4 (1)

Trial Status

Completed73
Unknown24
Terminated16
Withdrawn14
Recruiting2
Active Not Recruiting2

Trial Success Rate

82.0%

Benchmark: 86.5%

Based on 73 completed trials

Clinical Trials (132)

Showing 20 of 20 trials
NCT07224490Phase 1Recruiting

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

NCT04444609Completed

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

NCT04405986Not ApplicableTerminatedPrimary

Exploring Brain Damages After COVID-19 Infection

NCT04568148Active Not Recruiting

COVID-19 Biorepository

NCT05137795Phase 3WithdrawnPrimary

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

NCT04359693CompletedPrimary

Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections

NCT04405362WithdrawnPrimary

Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry

NCT04797091Completed

Kidney in Coronavirus Disease 2019 Registry

NCT04392388CompletedPrimary

Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis

NCT04448145Recruiting

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

NCT04405271Phase 3Terminated

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

NCT04408183Phase 2TerminatedPrimary

GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)

NCT04448717CompletedPrimary

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

NCT04853004Active Not RecruitingPrimary

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations

NCT04413955Completed

Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA

NCT04492514Phase 2Completed

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

NCT04390503Phase 2TerminatedPrimary

Convalescent Plasma for Early Treatment of COVID-19

NCT04378686CompletedPrimary

Serological Testing for COVID-19 (SARS-CoV-2) in ESKD

NCT04437706Completed

Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling

NCT04397523Not ApplicableCompleted

Efficacy and Safety of COVID-19 Convalescent Plasma

Scroll to load more

Research Network

Activity Timeline